Explore the words cloud of the APAC project. It provides you a very rough idea of what is the project "APAC" about.
The following table provides information about the project.
SCANDINAVIAN CHEMOTECH AB
|Coordinator Country||Sweden [SE]|
|Total cost||71˙429 €|
|EC max contribution||50˙000 € (70%)|
1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
|Duration (year-month-day)||from 2019-07-01 to 2019-12-31|
Take a look of project's partnership.
|1||SCANDINAVIAN CHEMOTECH AB||SE (MALMO)||coordinator||50˙000.00|
This Phase 1 project will enable Scandinavian ChemoTech AB (ChemoTech) to develop a business plan for Dynamic-ElectroEnhanced Pain Control (D-EEPC). This will include clinical and market feasibility, with a strong business development and commercialisation strategy. Approximately 25% of all cancer patients are affected by secondary bone cancer; which is difficult to find and treat. 20-30% of these patients do not respond to current systemic therapies and pain control with narcotic analgesics, radiation therapy and surgery. This patient population continues to experience potentially debilitating back pain. To address this, ChemoTech has developed D-EEPC - a game-changing pain reduction treatment for secondary bone cancer. It operates by sending short, high voltage electric pulses in combination with a low concentration of a cytostatic drug to reduce tumour size in the spine or bones. This reduces pain caused by pressure on nerves. The different voltage settings and use of an applicator with different sizes allows treatment of hard-to-treat cancers and distinguishes D-EEPC from its competitors. Development of D-EEPC and research supporting its efficacy and safety to date is extremely promising but requires full clinical validation and an optimal business strategy. The proposed Phase 1 project will enable the company to define the pathway to implement for successful commercialisation.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "APAC" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (email@example.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "APAC" are provided by the European Opendata Portal: CORDIS opendata.
First in the world ecological and sustainable cream for wound care, based on microalgaprasinococcus capsulatusRead More
FAST-RESPONSIVE and LONG-LASTING TRANSPARENT PHOTOCHROMIC FILMSRead More
MCBD (MULTI-CORE BIOPSY DEVICE) INNOVATIVE BIOPSY TECHNOLOGY FOR THE NEW ERA OF TARGETED MEDICINERead More